ChartMill assigns a Buy % Consensus number of 48% to EXAI. The Buy consensus is the weighted average rating of the current analysts ratings.
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2024-08-13 | Barclays | Downgrade | Overweight -> Equal-Weight |
| 2024-08-09 | TD Cowen | Downgrade | Buy -> Hold |
| 2024-07-29 | Barclays | Maintains | Overweight -> Overweight |
| 2024-07-09 | TD Cowen | Initiate | Buy |
| 2024-04-22 | Morgan Stanley | Maintains | Equal-Weight -> Equal-Weight |
| 2024-01-05 | B of A Securities | Downgrade | Buy -> Neutral |
| 2023-10-17 | Barclays | Maintains | Overweight -> Overweight |
| 2023-10-11 | Morgan Stanley | Maintains | Equal-Weight -> Equal-Weight |
| 2023-08-01 | Morgan Stanley | Reiterate | Equal-Weight -> Equal-Weight |
| 2023-07-31 | Morgan Stanley | Reiterate | Equal-Weight -> Equal-Weight |
| 2023-07-24 | Morgan Stanley | Reiterate | Equal-Weight -> Equal-Weight |
| 2023-07-21 | Berenberg | Initiate | Buy |
| 2023-07-20 | Morgan Stanley | Reiterate | Equal-Weight -> Equal-Weight |
| 2023-07-17 | Morgan Stanley | Reiterate | Equal-Weight -> Equal-Weight |
| 2023-06-26 | Morgan Stanley | Reiterate | Equal-Weight -> Equal-Weight |
| 2023-06-20 | Morgan Stanley | Reiterate | Equal-Weight |
| 2023-06-12 | Morgan Stanley | Reiterate | Equal-Weight |
| 2023-04-10 | Morgan Stanley | Maintains | Equal-Weight |
| 2022-11-16 | Barclays | Maintains | Overweight |
| 2022-09-09 | Morgan Stanley | Maintains | Equal-Weight |
| 2022-08-24 | Morgan Stanley | Maintains | Equal-Weight |
| 2022-06-13 | Morgan Stanley | Maintains | Equal-Weight |
| 2022-05-24 | Goldman Sachs | Maintains | Buy |
| 2022-04-11 | Morgan Stanley | Maintains | Equal-Weight |
| 2021-10-26 | Goldman Sachs | Initiate | Buy |
| 2021-10-26 | B of A Securities | Initiate | Buy |
| 2021-10-26 | Morgan Stanley | Initiate | Equal-Weight |
8 analysts have analysed EXAI and the average price target is 5.46 USD. This implies a price increase of 12.75% is expected in the next year compared to the current price of 4.84.
The consensus rating for EXSCIENTIA PLC (EXAI) is 47.5 / 100 . This indicates that analysts generally have a neutral outlook on the stock.
The number of analysts covering EXSCIENTIA PLC (EXAI) is 8.